Users' guides to the medical literature - XX. Integrating research evidence with the care of the individual patient

Citation
Fa. Mcalister et al., Users' guides to the medical literature - XX. Integrating research evidence with the care of the individual patient, J AM MED A, 283(21), 2000, pp. 2829-2836
Citations number
76
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
ISSN journal
00987484 → ACNP
Volume
283
Issue
21
Year of publication
2000
Pages
2829 - 2836
Database
ISI
SICI code
0098-7484(20000607)283:21<2829:UGTTML>2.0.ZU;2-0
Abstract
Clinicians can use research results to determine optimal care for an indivi dual patient by using a patient's baseline risk estimate, clinical predicti on guidelines that quantitate an individual patient's potential for benefit , and published articles. We propose that when clinicians are determining t he likelihood that treatment will prevent the target event (at the expense of adverse events) in a patient that they also incorporate the patient's va lues. The 3 main elements to joint clinical decision making are disclosure of information about the risks and benefits of therapeutic alternatives, ex ploration of the patient's values about both the therapy and potential outc omes, and the actual decision. In addressing the patient's risk of adverse events without treatment and risk of harm with therapy, clinicians must rec ognize that patients are rarely identical to the average study patient. Dif ferences between study participants and patients in real-world practice ten d to be quantitative (differences in degree of risk of the outcome or respo nsiveness to therapy) rather than qualitative (no risk or adverse response to therapy). The number needed to treat and number needed to harm can be us ed to generate patient-specific estimates relative to the risk of the outco me event, Clinicians must consider a patient's risk of adverse events from any intervention and incorporate the patient's values in clinical decision making by using information about the risks and benefits of therapeutic alt ernatives.